Description
Laferon-FarmBiotek Lyophilisate for Solution for Injections 3 mln IU №10 Vial
Ingredients:
Each vial contains 3 million international units of Interferon alfa-2b.
Mechanism of Action:
Interferon alfa-2b exhibits antiviral, antiproliferative, and immunomodulatory effects, contributing to its efficacy in combating viral infections and certain types of cancer.
Pharmacological Properties:
Laferon-FarmBiotek contains Interferon alfa-2b, which acts by modulating the immune response and inhibiting viral replication, thus exerting its therapeutic effects.
Indications for Use:
Laferon-FarmBiotek is indicated for the treatment of certain viral infections, including hepatitis B and C, as well as certain types of cancer such as melanoma and leukemia.
Contraindications:
Avoid using Laferon-FarmBiotek if allergic to Interferon alfa-2b or any other components. It is contraindicated in patients with autoimmune disorders.
Side Effects:
Common side effects of Laferon-FarmBiotek may include flu-like symptoms, fatigue, and injection site reactions. Regular monitoring is crucial during therapy.
Usage Instructions:
The dosage of Laferon-FarmBiotek should be determined by a healthcare professional based on the individual’s condition. It is typically administered via subcutaneous or intramuscular injection.
Benefits Compared to Analogues:
Laferon-FarmBiotek offers advantages over other treatments due to its potent antiviral and antiproliferative properties, making it effective in combating specific viral infections and cancers.
Suitable Patient Groups:
Laferon-FarmBiotek is suitable for adults and may be used in pediatric populations under healthcare provider supervision. Caution is advised in elderly patients.
Storage and Shelf Life:
Store Laferon-FarmBiotek as per the instructions provided on the packaging. Ensure proper storage conditions to maintain its stability and efficacy. Check the expiration date before use.
Packaging Description:
Laferon-FarmBiotek is available in vials containing the lyophilized powder for reconstitution. Each package includes 10 vials.
Clinical Evidence and Proven Effectiveness:
Research published in the Journal of Viral Hepatitis highlighted the efficacy of Interferon alfa-2b in treating chronic hepatitis C, showing high rates of sustained virological response in patients.
